CMC and Manufacturing
Dr. Carlos Garcia is a leader in the biotech/ pharma industry. Having worked at a number of successful start-ups and large pharmaceutical companies such as Rinat, Pfizer, Arresto, Gilead and more, Dr. Garcia has overseen CMC related activities for several biotherapeutic programs. Dr. Garcia is now the CTO of Rakuten Aspyrian which has developed a novel photoimmunotherapy-based ADC platform targeting a broad range of solid tumors. With broad expertise in pilot and commercial manufacturing and CMC-related development, Dr. Garcia frequently advises Celltheon on tech transfer strategy and CMC operations.